Publications by authors named "Harald Fuss"

Claim this Profile
P
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.
Manuela A Hoechstetter, Raymonde Busch, Barbara Eichhorst, Andreas Bühler, Dirk Winkler, Harald Fuss

Leukemia· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo detection of changes in cutaneous carotenoids after chemotherapy using shifted excitation resonance Raman difference and fluorescence spectroscopy.
Sora Jung, Maxim E Darvin, Johannes Schleusener, Gisela Thiede, Juergen Lademann, Harald Fuss

Skin Res Technol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Sorafenib, Sunitinib and Capecitabine on the Antioxidant Status of the Skin.
Harald Fuss, Juergen Lademann, Sora Jung

Anticancer Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Chemotherapy on the Antioxidant Status of Human Skin.
Bich Na Lee, Sora Jung, Maxim E Darvin, Jan Eucker, Dagmar Kühnhardt, Harald Fuss

Anticancer Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of capecitabine (Xeloda®) on the skin surface after oral administration.
Mao-Dong Huang, Harald Fuss, Jürgen Lademann, Stefan Florek, Alexa Patzelt

J Biomed Opt· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG).
Hubert Köppler, Harald Fuss, Hans J Hurtz, Owe Knigge, Christoph Losem

Br J Haematol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis